Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Lanreotide: A long-acting somatostatin for acromegaly.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Tanzi, Maria G.
- Source:
Pharmacy Today. Oct2007, Vol. 13 Issue 10, p33-33. 1p.
- Subject Terms:
- Additional Information
- Abstract:
The article features the lanreotide injection, a somatostatin for the long-term treatment of patients with acromegaly. The disorder develops when the somatotrophs or the cells in the anterior pituitary glands multiply and oversecrete growth hormone. Lanreotide binds to the human somatostatin receptors 2 and 5 and suppresses the production of growth hormones.
No Comments.